Literature DB >> 11574625

V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.

J C Plantier1, F Damond, S Souquières, F Brun-Vézinet, F Simon, F Barin.   

Abstract

V3 enzyme immunoassays have been shown to discriminate effectively between human immunodeficiency virus type 1 (HIV-1) subtypes. The aim of this study was to investigate the feasibility of V3 serotyping for HIV-2 infection. We serotyped 29 sera with three peptides, corresponding to the V3 loop of subtypes A, B, and D of HIV-2. Sera were collected from HIV-2-infected patients, whose infecting strains were sequenced and subjected to phylogenetic analysis. Our results indicate that HIV-2 serotyping using V3 peptides is not relevant. V3 serotyping data were not consistent with genotyping results. The V3-A and V3-D peptides displayed poor discrimination, and the V3-B peptide was not representative of circulating viruses. Comparison of amino acid sequences and serotype reactivities demonstrated the importance of positions 309 and 314, located on either side of the tip of the V3 loop, in antibody binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574625      PMCID: PMC88441          DOI: 10.1128/JCM.39.10.3803-3807.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau.

Authors:  H Norrgren; S Marquina; T Leitner; P Aaby; M Melbye; A G Poulsen; O Larsen; F Dias; D Escanilla; S Andersson; J Albert; A Nauclér
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-09-01

2.  Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion.

Authors:  F Barin; A M Courouce; J Pillonel; L Buzelay
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

3.  Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS.

Authors:  A Heredia; A Vallejo; V Soriano; A Aguilera; A Mas; J S Epstein; I K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  1997-07-01       Impact factor: 2.205

4.  Serological and virological characterization of HIV-1 group O infection in Cameroon.

Authors:  P Mauclère; I Loussert-Ajaka; F Damond; P Fagot; S Souquières; M Monny Lobe; F X Mbopi Keou; F Barré-Sinoussi; S Saragosti; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1997-03-15       Impact factor: 4.177

5.  Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.

Authors:  A Heredia; A Vallejo; V Soriano; M Gutierrez; S Puente; J S Epstein; I K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  1997-03-20       Impact factor: 2.205

6.  Phylogenetic analysis of HIV type 2 in Ghana and intrasubtype recombination in HIV type 2.

Authors:  J Takehisa; M Osei-Kwasi; N K Ayisi; O Hishida; T Miura; T Igarashi; J Brandful; W Ampofo; V B Netty; M Mensah; M Yamashita; E Ido; M Hayami
Journal:  AIDS Res Hum Retroviruses       Date:  1997-05-01       Impact factor: 2.205

7.  HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau.

Authors:  Z Xiang; K Ariyoshi; A Wilkins; F Dias; H Whittle; J Breuer
Journal:  AIDS Res Hum Retroviruses       Date:  1997-04-10       Impact factor: 2.205

8.  Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.

Authors:  F Barin; Y Lahbabi; L Buzelay; B Lejeune; A Baillou-Beaufils; F Denis; C Mathiot; S M'Boup; V Vithayasai; U Dietrich; A Goudeau
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-01       Impact factor: 2.205

9.  Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993.

Authors:  A Sönnerborg; S Durdevic; J Giesecke; M Sällberg
Journal:  AIDS Res Hum Retroviruses       Date:  1997-03-01       Impact factor: 2.205

10.  Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.

Authors:  Z Chen; A Luckay; D L Sodora; P Telfer; P Reed; A Gettie; J M Kanu; R F Sadek; J Yee; D D Ho; L Zhang; P A Marx
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more
  3 in total

1.  Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

Authors:  Jean-Christophe Plantier; Marie Gueudin; Fabienne de Oliveira; Florence Damond; Véronique Lemée; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

2.  HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs.

Authors:  Zsófia Ilona Szojka; Sara Karlson; Emil Johansson; Gülşen Özkaya Şahin; Marianne Jansson
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.

Authors:  Helena Barroso; Pedro Borrego; Inês Bártolo; José Maria Marcelino; Carlos Família; Alexandre Quintas; Nuno Taveira
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.